Dr. Marija Mioč
Ruđer Bošković Institute
Bijenička 54
HR-10000 Zagreb
Publications - journal articles
Izvorni znanstveni rad
-
Marjanović, Marko; Mikecin Dražić, Ana-Matea; Mioč, Marija; Paradžik, Mladen; Kliček, Filip; Novokmet, Mislav; Lauc, Gordan; Kralj, Marijeta | Salinomycin disturbs Golgi function and specifically affects cells in epithelial-to-mesenchymal transition // Journal of cell science, 136 (2023), 17; ---
journals.biologists.com -
Marjanović, Marko ; Mikecin Dražić, Ana-Matea ; Mioč, Marija ; Paradžik, Mladen ; Kliček, Filip ; Novokmet, Mislav ; Lauc, Gordan ; Kralj, Marijeta | Salinomycin disturbs Golgi apparatus function and specifically affects cells in epithelial-to-mesenchymal transition // Journal of cell science, 136 (2023), 17; jcs260934, 15. doi: 10.1242/jcs.260934
doiwww.biorxiv.orgjournals.biologists.com -
Poje, Goran ; Marinović, Marina ; Pavić, Kristina ; Mioč, Marija ; Kralj, Marijeta ; Pessanha de Carvalho, Lais ; Held, Jana ; Perković, Ivana ; Rajić, Zrinka | Harmicens, Novel Harmine and Ferrocene Hybrids: Design, Synthesis and Biological Activity // International journal of molecular sciences, 23 (2022), 9315, 20. doi: 10.3390/ijms23169315
doiwww.mdpi.comdoi.orgfulir.irb.hr -
Mioč, Marija ; Telbisz, Ágnes ; Radman, Katarina ; Bertoša, Branimir ; Šumanovac, Tatjana ; Sarkadi, Balázs ; Kralj, Marijeta | Interaction of crown ethers with the ABCG2 transporter and their implication for multidrug resistance reversal // Histochemistry and cell biology, 158 (2022), 261-277. doi: 10.1007/s00418-022-02106-z
doilink.springer.comdoi.org -
Beč, Anja ; Mioč, Marija ; Bertoša, Branimir ; Kos, Marija ; Debogović, Patricia ; Kralj, Marijeta ; Starčević, Kristina ; Hranjec, Marijana | Design, synthesis, biological evaluation and QSAR analysis of novel N-substituted benzimidazole derived carboxamides // Journal of enzyme inhibition and medicinal chemistry, 37 (2022), 1; 1327-1339. doi: 10.1080/14756366.2022.2070910
doiwww.tandfonline.comdx.doi.org -
Lončar, Borka ; Perin, Nataša ; Mioč, Marija ; Boček, Ida ; Grgić, Lea ; Kralj, Marijeta ; Tomić, Sanja ; Radić Stojković, Marijana ; Hranjec, Marijana | Novel amino substituted tetracyclic imidazo[4,5-b]pyridine derivatives: Design, synthesis, antiproliferative activity and DNA/RNA binding study // European journal of medicinal chemistry, 217 (2021), 113342, 18. doi: 10.1016/j.ejmech.2021.113342
doiwww.sciencedirect.comdx.doi.org -
Meščić Macan, Andrijana ; Perin, Nataša ; Jakopec, Silvio ; Mioč, Marija ; Radić Stojković, Marijana ; Kralj, Marijeta ; Hranjec, Marijana ; Raić-Malić, Silvana | Synthesis, antiproliferative activity and DNA/RNA-binding properties of mono- and bis-(1,2,3-triazolyl)-appended benzimidazo[1,2-a]quinoline derivatives // European journal of medicinal chemistry, 185 (2020), 111845, 11. doi: 10.1016/j.ejmech.2019.111845
doiwww.sciencedirect.comdx.doi.org -
Cindrić, Maja ; Sović, Irena ; Mioč, Marija ; Hok, Lucija ; Boček, Ida ; Roškarić, Petra ; Butković, Kristina ; Martin-Kleiner, Irena ; Starčević, Kristina ; Vianello, Robert et al. | Experimental and computational study of the antioxidative potential of novel nitro and amino substituted benzimidazole/benzothiazole-2-carboxamides with antiproliferative activity // Antioxidants, 8 (2019), 10; 477, 22. doi: 10.3390/antiox8100477
doidx.doi.orgwww.mdpi.comfulir.irb.hr -
Guberović, Iva ; Marjanović, Marko ; Mioč, Marija ; Ester, Katja ; Martin-Kleiner, Irena ; Šumanovac Ramljak, Tatjana ; Mlinarić-Majerski, Kata ; Kralj, Marijeta | Crown ethers reverse P-glycoprotein-mediated multidrug resistance in cancer cells // Scientific reports, 8 (2018), 1; 14467, 14. doi: 10.1038/s41598-018-32770-y
doiwww.nature.comfulir.irb.hr
Publications - conference proceedings
Sažetak izlaganja sa skupa
Mioč, Marija ; Telbisz, Agnes ; Beus, Maja ; Rajić, Zrinka ; Zorc, Branka ; Sarkadi, Balazs ; Kralj, Marijeta | Primaquine derivatives reverse multidrug resistance of tumor cells by modulation of ABCG2 transporter activity // HDIR-6: Targeting Cancer” The 6th Meeting of the Croatian Association for Cancer Research with International Participation – Book of Abstracts. | 2022. str. 39-39
Poje, Goran ; Marinović, Marina ; Pavić, Kristina ; Mioč, Marija ; Kralj, Marijeta ; Pessanha de Carvalho, Lais ; Held, Jana ; Perković, Ivana ; Rajić, Zrinka | Design, Synthesis and Biological Activity of Harmicens // 6th Mini Symposium of Section of Medicinal and Pharmaceutical Chemistry, Book of abstracts. | Zagreb, 2022. str. 5-5
-
Pavić, Kristina ; Mioč, Marija ; Poje, Goran ; Kralj, Marijeta ; Rajić, Zrinka | Unutarstanična lokalizacija i utjecaj harmicena na stanični ciklus tumorskih stanica // FARMEBS, 10. Simpozij studenata farmacije i medicinske biokemije : Knjiga sažetaka. | Zagreb: Farmaceutsko-biokemijski fakultet Sveučilišta u Zagrebu, 2022. str. 31-31
drive.google.com Kralj, Marijeta ; Marjanović, Marko ; Mikecin Dražić, Ana-Matea ; Mioč ; Marija, Kliček ; Filip, Novokmet, Mislav ; Lauc, Gordan | Selective effects of ionophores targeting the Golgi apparatus in the epithelial-to-mesenchymal transition // Microscopy Conference 2021 Joint Meeting of Dreiländertagung & Multinational Congress on Microscopy : Procedeengs. | 2021. str. 657-657
-
Boček, Ida ; Lončar, Borka ; Kralj, Marijeta ; Mioč, Marija ; Grgić, Lea ; Radić Stojković, Marijana ; Hranjec, Marijana | Synthesis and biological activity of tetracyclic imidazo[4,5-b]pyridines // Book of abstracts, 18th Ružička Days: Today science – tomorrow industry. | Zagreb: Hrvatsko društvo kemijskih inženjera i tehnologa (HDKI), 2020. str. 128-128
www.hdki.hr -
Hranjec, Marijana ; Perin, Nataša ; Boček, Ida ; Lučić, Borka ; Kralj, Marijeta ; Mioč, Marija | Synthesis and antiproliferative activity of novel amino substituted tetracyclic imidazo[4,5- b]pyridine derivatives // 20th World Congress on Medicinal Chemistry and Drug Design. | 2020, 1, 1
medicinalchemistry.pharmaceuticalconferences.commedicinalchemistry.pharmaceuticalconferences.com Mioč, Marija ; Marjanović, Marko ; Guberović, Iva ; Kralj, Marijeta | Crown ethers are able to reverse multidrug resistance and affect mitochondrial function in cancer cells // FEBS3+ Conference: From Molecules to Living Systems : Final Programme & Book of Abstracts. | Veszprém, 2018. str. 147-147
Marjanović, Marko ; Mioč, Marija ; Ester, Katja ; Kralj, Marijeta | The effects of potassium ionophores on mitochondrial homeostasis in breast cancer stem cell model // EMBO workshop: Mitochondria, apoptosis and cancer: book of abstracts. | Ljubljana: Abografika, 2017. str. 74-74
Ester, Katja ; Mioč, Marija ; Gabrilo, Jelena ; Uzelac, Lidija ; Marjanović, Marko ; Spurny, Pavel ; Bonhenry, Daniel ; Šumanovac-Ramljak, Tatjana ; Jost, Ludwig ; Mlinarić-Majerski, Kata et al. | Crown ether compound 613 as a small molecule with good antitumor potential: investigation of membrane perturbation and changes in ion homeostasis // COST BM 1406 Eight Meeting : Abstract Book. | 2018. str. 24-24
Publications - Conference journals
Sažetak izlaganja sa skupa
-
Mioč, Marija ; Marjanović, Marko ; Guberović, Iva ; Kralj, Marijeta | Proprietary crown ethers reverse multidrug resistance and affect mitochondrial function in cancer cells // Libri oncologici : Croatian journal of oncology, 2018. str. 63-63
hrcak.srce.hr
Prošireni sažetak izlaganja sa skupa
Ester, Katja; Mioč, Marija; Spurny, Pavel; Bonhenry, Daniel; Uzelac, Lidija; Šumanovac, Tatjana; Majerski, Kata; Minofar, Babak; Ludwig, Jost; Kralj, Marijeta | Small hydrophobic molecules in multi-targeted cancer therapy: disruption of plasma membrane and mitochondrial functions // Oncology insights, 1, 2023. str. 30-31
Publications - Graded papers
Doktorska disertacija
-
Mioč, Marija | Povećanje osjetljivosti tumorskih stanica na terapiju modulacijom aktivnosti transportera ABCB1 i ABCG2 diaza krunastim eterima i derivatima primakina / Kralj, Marijeta (mentor). | Osijek, 2022
mobi.unios.hr
Other Publications
Rukopis
-
Marjanović, Marko ; Dražić, Ana-Matea Mikecin ; Mioč, Marija ; Kliček, Filip ; Novokmet, Mislav ; Lauc, Gordan ; Kralj, Marijeta | Salinomycin disturbs Golgi apparatus function and specifically affects cells in epithelial-to- mesenchymal transition // BioRxiv. 2022.
www.biorxiv.org